Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors

Genes Chromosomes and Cancer

Volumn 35, Issue 2, 2002, Pages 176-181

  Arcellana Panlilio, Mayi Y ^a,b   Egeler, R Maarten ^a,b   Ujack, Eva ^a,b   Magliocco, Anthony ^a   Stuart, Gavin C E ^a   Robbins, Stephen M ^a,b,d   Coppes, Max J ^a,b,c,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c ALBERTA CHILDREN'S HOSPITAL   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE INHIBITOR;

ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENE TARGETING; GRANULOSA CELL TUMOR; HUMAN; HUMAN TISSUE; MULTIGENE FAMILY; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P18; CYCLIN-DEPENDENT KINASE INHIBITOR P19; CYCLIN-DEPENDENT KINASES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ENZYME INHIBITORS; FEMALE; GRANULOSA CELL TUMOR; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEINS;

EID: 0036778643     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10108     Document Type: Article

References (38)

1. Prognostic significance of p53 expression in ovarian granulosa cell tumors
2. Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors
3. Crosstalk among multiple signaling pathways controlling ovarian cell death
4. Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor
5. Granulosa-cell and theca-cell tumors. The clinical picture and long-term outcome for the Radiumhemmet series
6. Prognostic factors in granulosa-cell tumors
7. Analysis of WT1 in granulosa cell and other sex cord-stromal tumors
8. A clinicopathologic study of 92 cases of granulosa cell tumor of the ovary with special reference to the factors influencing prognosis
9. No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors
10. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-beta2/PE40
11. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
12. Isolation and characterization of p19INK4D, a p16-related inhibitor specific to CDK6 and CDK4
13. Mdm2 promotes the rapid degradation of p53
14. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
15. Gonadotropic control of ovarian follicular growth and development
16. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
17. p16 is a major inactivation target in hepatocellular carcinoma
18. Cyclin-dependent kinase inhibitors and human cancer
19. p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry
20. p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma
21. Absence of mutations in the FSH receptor in ovarian granulosa cell tumors
22. A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors
23. Regulation of p53 stability by Mdm2
24. Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors
25. Overexpression of p53 is not a feature of ovarian granulosa cell tumors
26. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors
27. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice
28. Prognostic factors in adult granulosa cell tumor of the ovary
29. High prevalence of p16 genetic alterations in head and neck turnouts
30. Alteration of p16 and p15 genes in human uterine turnouts
31. Expression of the Wilms' tumor gene WT1 in the murine urogenital system
32. Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinoma
33. Role of the INK4A locus in tumor suppression and cell mortality
34. CDKN2/p16 or RB alterations occur in the majority, of glioblastomas and are inversely correlated
35. Monosomy 22 and trisomy 14 may be early events in the tumorigenesis of adult granulosa cell tumor
36. Loss of heterozygosity at the alpha-inhibin locus on chromosome 2q is not a feature of human granulosa cell tumors
37. Sex cord-stromal tumors, steroid cell tumors and other ovarian tumors with endocrine, paraendocrine and paraneoplastic manifestations
38. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4A locus deletion impairs both the Rb and p53 tumor suppression pathways